(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of -1.01% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Quidelortho's revenue in 2024 is $2,997,800,000.On average, 4 Wall Street analysts forecast QDEL's revenue for 2024 to be $188,676,334,823, with the lowest QDEL revenue forecast at $183,524,578,877, and the highest QDEL revenue forecast at $195,419,108,632. On average, 4 Wall Street analysts forecast QDEL's revenue for 2025 to be $196,079,381,045, with the lowest QDEL revenue forecast at $184,028,624,031, and the highest QDEL revenue forecast at $208,384,567,218.
In 2026, QDEL is forecast to generate $204,882,990,932 in revenue, with the lowest revenue forecast at $204,882,990,932 and the highest revenue forecast at $204,882,990,932.